IBOV 168,283.13 ▲ 0.27% IPSA 11,207.55 ▼ 0.30% IPC MEX 63,999.26 ▲ 0.10% MERVAL 2,891,094 ▲ 0.58% COLCAP 2,439.29 ▼ 0.59% BVL PERÚ 58,380.78 ▲ 0.50% USD/BRL5.19▲ 0.35% USD/MXN16.96▲ 0.08% USD/CLP924.12▲ 0.30% USD/COP3,061▼ 1.45% USD/PEN3.35▼ 0.41% USD/ARS1,498▲ 0.05% USD/UYU40.21▲ 0.95% USD/PYG5,992▲ 1.19% USD/BOB11.42▲ 0.14% USD/DOP58.82▲ 1.31% USD/CRC446.30▲ 2.09% USD/GTQ7.62▲ 2.24% USD/HNL26.81▲ 1.60% USD/NIO36.62▲ 0.69% USD/VES775.47▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.71▲ 0.93% EUR/BRL6.07▲ 0.57% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 168,283.13 ▲ 0.27% IPSA 11,207.55 ▼ 0.30% IPC MEX 63,999.26 ▲ 0.10% MERVAL 2,891,094 ▲ 0.58% COLCAP 2,439.29 ▼ 0.59% BVL PERÚ 58,380.78 ▲ 0.50% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Thursday, August 20, 2026

Covid-19 Brazil

Bolsonaro Says Brazil May Purchase Moderna’s Covid-19 Vaccine

By · January 2, 2021 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL –  President Jair Bolsonaro said on Thursday, December 31st, without providing details, that Brazil may also purchase Moderna’s vaccine against Covid-19.

During his weekly live stream, the President again said that the government will offer vaccines to the part of the population interested in being immunized against the coronavirus, and reiterated once more that he will not take the vaccine against Covid-19, explaining that he has already been infected, although there have been cases of re-infection registered.

President Jair Bolsonaro said on Thursday, December 31st, without providing details, that Brazil may also purchase Moderna's vaccine against Covid-19.
President Jair Bolsonaro said on Thursday, December 31st, without providing details, that Brazil may also purchase Moderna’s vaccine against Covid-19. (Photo internet reprodudction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Moderna had its vaccine authorized for emergency use by the United States on December 19th.

At the moment, Brazil is negotiating with Pfizer, which has developed a vaccine together with BioNTech, to acquire its immunizer against Covid-19. “So, in addition to Pfizer, we have another one now, Moderna, which may be purchased by Brazil,” said Bolsonaro.

“It seems that the companies will now submit documentation to ANVISA, for ANVISA to then certify them, so we can immediately arrange things and purchase these vaccines”, he added. “Also because part of the population is demanding them, so, anyone who wants the vaccine will get it, from us, free and not compulsory.”

The federal government currently has an agreement with AstraZeneca, which has developed a vaccine against Covid-19 in partnership with Oxford University.

On Thursday, Nísia Trindade, the President of Fiocruz, AstraZeneca’s partner in Brazil, told Reuters that she intends to apply for this vaccine’s emergency use at ANVISA. The AstraZeneca-Oxford immunizer had its emergency use authorized by the United Kingdom on Wednesday.

In addition to these, Brazil is also involved in testing CoronaVac, a vaccine developed by Chinese Sinovac, which will be produced in Brazil by the Butantan Institute, linked to the São Paulo state government.

The Ministry of Health reported that Brazil registered 1,074 deaths from the coronavirus on Thursday, raising the total to 194,949, the second highest death toll in the world, behind only the United States. According to the ministry, 7,675,973 people have already been infected in the country, the third highest number in the world.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.